The postponement of the India-Africa Forum Summit IV, initially due to the Ebola outbreak, has highlighted Africa’s reliance on external sources for vaccine access. India is increasingly important in addressing this dependency, particularly as African nations face ongoing public health challenges. The situation prompts scrutiny of the continent’s capacity for independent vaccine production and procurement. While the summit’s delay is unfortunate, India continues to provide pharmaceutical support to its African partners. This support is crucial given the disruption caused by global health crises and supply chain vulnerabilities. The ongoing relationship demonstrates India’s role as a key partner in strengthening Africa’s healthcare infrastructure and pandemic preparedness. Further discussion is needed regarding long-term solutions to ensure sustainable vaccine security for African countries.